Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) EPS (Basic) (2021 - 2025)

Historic EPS (Basic) for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to -$0.85.

  • HeartSciences' EPS (Basic) rose 6255.51% to -$0.85 in Q4 2025 from the same period last year, while for Oct 2025 it was -$6.88, marking a year-over-year increase of 1190.78%. This contributed to the annual value of -$9.44 for FY2025, which is 4964.99% up from last year.
  • As of Q4 2025, HeartSciences' EPS (Basic) stood at -$0.85, which was up 6255.51% from -$1.58 recorded in Q3 2025.
  • Over the past 5 years, HeartSciences' EPS (Basic) peaked at $0.11 during Q2 2024, and registered a low of -$79.36 during Q2 2023.
  • Over the past 5 years, HeartSciences' median EPS (Basic) value was -$1.22 (recorded in 2025), while the average stood at -$6.98.
  • As far as peak fluctuations go, HeartSciences' EPS (Basic) tumbled by 1290983.61% in 2023, and later surged by 10013.86% in 2024.
  • Over the past 5 years, HeartSciences' EPS (Basic) (Quarter) stood at -$0.31 in 2021, then grew by 29.03% to -$0.22 in 2022, then tumbled by 7136.36% to -$15.92 in 2023, then skyrocketed by 85.74% to -$2.27 in 2024, then skyrocketed by 62.56% to -$0.85 in 2025.
  • Its last three reported values are -$0.85 in Q4 2025, -$1.58 for Q3 2025, and -$2.24 during Q2 2025.